{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T12:12:40Z","timestamp":1783944760808,"version":"3.55.0"},"reference-count":34,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"unspecified","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000200","name":"United States Agency for International Development","doi-asserted-by":"publisher","award":["7200AA20CA00005"],"award-info":[{"award-number":["7200AA20CA00005"]}],"id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020137","name":"Johnson and Johnson Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020137","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["bmjph"],"accepted":{"date-parts":[[2026,6,16]]},"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>New tuberculosis (TB) vaccines for adults and adolescents are crucial for achieving global control targets, and several candidates may be ready for introduction within 5 years. We conducted a convergent mixed-methods study in Lusaka, Zambia, among community members and healthcare workers (HCWs) to understand preliminary TB vaccine acceptance and potential factors influencing uptake to inform readiness activities critical for successful implementation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Adult community members were enrolled from randomly selected households within four communities with historically low COVID-19 vaccine coverage, and HCWs from 10 public healthcare facilities representing different care levels. Structured surveys evaluated participants\u2019 perspectives on new vaccines and mixed-effects Poisson regression was used to estimate the marginal probability of participants\u2019 intention to get a new TB vaccine. Qualitative in-depth interviews (IDIs; n=24) and focus group discussions (FGDs; n=9) were conducted and analysed using a hybrid approach to explore acceptable vaccine attributes, preferences and determinants of TB vaccine uptake and recommendations for rollout.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Overall, 499 participants completed surveys (395 community members and 104 HCWs) with 62 additional participants across IDIs and FGDs. 77% of community members and 83% of HCWs expressed intention to get a TB vaccine. Perceived TB risk and severity concerns were the only significant drivers of vaccine intention. Participants pragmatically accepted the WHO\u2019s preferred vaccine specifications (50% efficacy, two-dose schedule, transient, mild side effects, at least 2 years\u2019 duration) though HCWs preferred higher efficacy thresholds due to occupational risk. Implementation preferences emphasised early community engagement (at least 3\u20136 months pre-rollout), diverse delivery approaches, including facility-based and community venues for adults, schools for adolescents and door-to-door campaigns, while addressing COVID-19-related scepticism through transparent, clear communication using trusted sources.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study reveals strong potential for a successful TB vaccine rollout in Zambia through proactive implementation strategies, including early community engagement, transparent communication and person-centred delivery approaches.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjph-2025-003716","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T11:40:27Z","timestamp":1783942827000},"page":"e003716","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["\u2018Prevention is better than cure\u2019: a mixed methods study of communities\u2019 and healthcare workers\u2019 perspectives on new adult and adolescent TB vaccines and their implementation in Zambia"],"prefix":"10.1136","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5023-6658","authenticated-orcid":false,"given":"Andrew D","family":"Kerkhoff","sequence":"first","affiliation":[{"name":"Division of HIV, Infectious Diseases and Global Medicine, San Francisco General Hospital and Trauma Center, University of California San Francisco, San Francisco, California, USA"},{"name":"Center for Tuberculosis, University of California San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6312-4420","authenticated-orcid":false,"given":"Jake M","family":"Pry","sequence":"additional","affiliation":[{"name":"Division of Epidemiology, School of Medicine, University of California, Davis, Davis, California, USA"},{"name":"Centre for Infectious Disease Research in Zambia, Lusaka, Zambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mwiza","family":"Haambokoma","sequence":"additional","affiliation":[{"name":"Centre for Infectious Disease Research in Zambia, Lusaka, Zambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelle","family":"Le Tourneau","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, School of Medicine, Washington University in St. Louis, St. Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra S","family":"Simbeza","sequence":"additional","affiliation":[{"name":"Centre for Infectious Disease Research in Zambia, Lusaka, Zambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertha","family":"Shamoya","sequence":"additional","affiliation":[{"name":"Centre for Infectious Disease Research in Zambia, Lusaka, Zambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelly","family":"Zulu","sequence":"additional","affiliation":[{"name":"Centre for Infectious Disease Research in Zambia, Lusaka, Zambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"Nyirenda","sequence":"additional","affiliation":[{"name":"Centre for Infectious Disease Research in Zambia, Lusaka, Zambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1178-2362","authenticated-orcid":false,"given":"Evelyn","family":"Kunda-Ng\u2019andu","sequence":"additional","affiliation":[{"name":"Centre for Infectious Disease Research in Zambia, Lusaka, Zambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8187-8661","authenticated-orcid":false,"given":"Kombatende","family":"Sikombe","sequence":"additional","affiliation":[{"name":"Centre for Infectious Disease Research in Zambia, Lusaka, Zambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvin H","family":"Geng","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, School of Medicine, Washington University in St. Louis, St. Louis, Missouri, USA"},{"name":"Center for Dissemination and Implementation, Institute for Public Health, Washington University in St. Louis, St. Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupali J","family":"Limaye","sequence":"additional","affiliation":[{"name":"College of Public Health, Department of Global and Community Health, George Mason University, Fairfax, Virginia, USA"},{"name":"Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Sharma","sequence":"additional","affiliation":[{"name":"Centre for Infectious Disease Research in Zambia, Lusaka, Zambia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"2026071304401432000_4.3.e003716.1","unstructured":"STOP TB Partnership . The global plan to end TB 2023-2030. Geneva STOP TB Partnership; 2022."},{"key":"2026071304401432000_4.3.e003716.2","unstructured":"World Health Organization . Global tuberculosis report 2025. Geneva World Health Organization; 2025."},{"key":"2026071304401432000_4.3.e003716.3","doi-asserted-by":"crossref","first-page":"e1307","DOI":"10.1016\/S2214-109X(22)00283-2","article-title":"Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysis","volume":"10","author":"Martinez","year":"2022","journal-title":"Lancet Glob Health"},{"key":"2026071304401432000_4.3.e003716.4","unstructured":"Treatment Action Group . 2024 pipeline report: TB diagnostics. New York Treatment Action Group; 2024."},{"key":"2026071304401432000_4.3.e003716.5","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines12080891","article-title":"Lessons from the COVID-19 Pandemic: Promoting Vaccination and Public Health Resilience, a Narrative Review","volume":"12","author":"Pennisi","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"2026071304401432000_4.3.e003716.6","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00279-7"},{"key":"2026071304401432000_4.3.e003716.7","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines12101093","article-title":"A Scoping Review of Factors Affecting COVID-19 Vaccination Uptake and Deployment in Global Healthcare Systems","volume":"12","author":"Kandulu","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"2026071304401432000_4.3.e003716.8","unstructured":"COVID-19 Vaccine Delivery Partnership . The COVID-19 vaccination response: country experiences,best practices,and lessons. New York UNICEF; 2023."},{"key":"2026071304401432000_4.3.e003716.9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0000844","article-title":"Identifying priority challenges and solutions for COVID-19 vaccine delivery in low- and middle-income countries: A modified Delphi study","volume":"2","author":"Ariyarajah","year":"2022","journal-title":"PLOS Glob Public Health"},{"key":"2026071304401432000_4.3.e003716.10","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9040319","article-title":"Demand Creation for COVID-19 Vaccination: Overcoming Vaccine Hesitancy through Social Marketing","volume":"9","author":"Evans","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"2026071304401432000_4.3.e003716.11","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2021-006951","article-title":"\u2018Learn from the lessons and don\u2019t forget them\u2019: identifying transferable lessons for COVID-19 from meningitis A, yellow fever and Ebola virus disease vaccination campaigns","volume":"6","author":"Collins","year":"2021","journal-title":"BMJ Glob Health"},{"key":"2026071304401432000_4.3.e003716.12","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1080\/14760584.2024.2375329","article-title":"Lessons from a decade of adult vaccine rollout in low- and middle-income countries: a scoping review","volume":"23","author":"Gerste","year":"2024","journal-title":"Expert Rev Vaccines"},{"key":"2026071304401432000_4.3.e003716.13","first-page":"100657","article-title":"Adolescent Vaccine Introductions Scoping Review: A Decade of Insights from Low- and Middle-Income Countries (2013\u22122023)","volume":"25","author":"Majidulla","year":"2025","journal-title":"Vaccine: X"},{"key":"2026071304401432000_4.3.e003716.14","unstructured":"World Health Organization . WHO global framework to prepare for country introduction of new TB vaccines for adults and adolescents. Geneva World Health Organization; 2024."},{"key":"2026071304401432000_4.3.e003716.15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0002885","article-title":"Mapping the existing body of knowledge on new and repurposed TB vaccine implementation: A scoping review","volume":"4","author":"Buis","year":"2024","journal-title":"PLOS Glob Public Health"},{"key":"2026071304401432000_4.3.e003716.16","doi-asserted-by":"crossref","unstructured":"Sharma A , Kerkhoff AD , Haambokoma M , et al . Intention to receive new vaccines post-COVID-19 pandemic among adults and health workers in Lusaka, Zambia. Vaccine 2025;50. doi:10.1016\/j.vaccine.2025.126846","DOI":"10.1016\/j.vaccine.2025.126846"},{"key":"2026071304401432000_4.3.e003716.17","doi-asserted-by":"publisher","DOI":"10.1097\/ACM.0000000000000388"},{"key":"2026071304401432000_4.3.e003716.18","unstructured":"World Health Organization . Behavioural and social drivers of vaccination tools and practical guidance for achieving high uptake. Geneva World Health Organization; 2022."},{"key":"2026071304401432000_4.3.e003716.19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208601","article-title":"Beyond confidence: Development of a measure assessing the 5C psychological antecedents of vaccination","volume":"13","author":"Betsch","year":"2018","journal-title":"PLoS One"},{"key":"2026071304401432000_4.3.e003716.20","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-8-70"},{"key":"2026071304401432000_4.3.e003716.21","doi-asserted-by":"publisher","DOI":"10.1177\/104973230201200611"},{"key":"2026071304401432000_4.3.e003716.22","unstructured":"Miles MB , Huberman AM . Qualitative data analysis: an expanded sourcebook. SAGE Publications, 1994."},{"key":"2026071304401432000_4.3.e003716.23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/160940690200100202","article-title":"Verification Strategies for Establishing Reliability and Validity in Qualitative Research","volume":"1","author":"Morse","year":"2002","journal-title":"Int J Qual Methods"},{"key":"2026071304401432000_4.3.e003716.24","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF00117559","article-title":"Zezuru turn of the screw","volume":"14","author":"Reynolds","year":"1990","journal-title":"Cult Med Psych"},{"key":"2026071304401432000_4.3.e003716.25","unstructured":"World Health Organization . Evidence considerations for vaccine policy development for tuberculosis vaccines intended for adults and adolescents. Geneva WHO; 2024."},{"key":"2026071304401432000_4.3.e003716.26","unstructured":"WHO . WHO consolidated guidelines on tuberculosis, module 1: prevention - tuberculosis preventive treatment. Geneva World Health Organization; 2021."},{"key":"2026071304401432000_4.3.e003716.27","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.1097\/INF.0000000000004699","article-title":"High Intention to Vaccinate Against Tuberculosis During Pregnancy and Lactation: Understanding Vaccine-specific Maternal Immunization Acceptance in Amhara, Ethiopia","volume":"44","author":"Quincer","year":"2025","journal-title":"Pediatr Infect Dis J"},{"key":"2026071304401432000_4.3.e003716.28","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/aphw.12262","article-title":"The health belief model predicts vaccination intentions against COVID\u201019: A survey experiment approach","volume":"13","author":"Zampetakis","year":"2021","journal-title":"Appl Psychol Health Well Being"},{"key":"2026071304401432000_4.3.e003716.29","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10060973","article-title":"The Health Belief Model Applied to COVID-19 Vaccine Hesitancy: A Systematic Review","volume":"10","author":"Limbu","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"2026071304401432000_4.3.e003716.30","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.vaccine.2023.01.066","article-title":"Real-world uptake of COVID-19 vaccination among individuals expressing vaccine hesitancy: A registry-linkage study","volume":"41","author":"Andrejko","year":"2023","journal-title":"Vaccine"},{"key":"2026071304401432000_4.3.e003716.31","unstructured":"USAID . Lessons learned from emergency COVID-19 vaccination programs across 28 countries. Washington DC USAID; 2023."},{"key":"2026071304401432000_4.3.e003716.32","doi-asserted-by":"crossref","DOI":"10.1186\/s40249-022-01021-8","article-title":"Interventions pathways to reduce tuberculosis-related stigma: a literature review and conceptual framework","volume":"11","author":"Nuttall","year":"2022","journal-title":"Infect Dis Poverty"},{"key":"2026071304401432000_4.3.e003716.33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0000989","article-title":"Analysing interventions designed to reduce tuberculosis-related stigma: A scoping review","volume":"2","author":"Foster","year":"2022","journal-title":"PLOS Glob Public Health"},{"key":"2026071304401432000_4.3.e003716.34","doi-asserted-by":"publisher","DOI":"10.1287\/mnsc.1040.0264"}],"container-title":["BMJ Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjph-2025-003716","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T11:40:32Z","timestamp":1783942832000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjpublichealth.bmj.com\/lookup\/doi\/10.1136\/bmjph-2025-003716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":34,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,7,13]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1136\/bmjph-2025-003716"],"URL":"https:\/\/doi.org\/10.1136\/bmjph-2025-003716","relation":{},"ISSN":["2753-4294"],"issn-type":[{"value":"2753-4294","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}